MeSH term
Frequency | Condition_Probility | Adult | 30 | 0.0 |
Comparative Study | 10 | 0.0 |
Female | 27 | 0.0 |
Humans | 83 | 0.0 |
Male | 38 | 0.0 |
Reproducibility of Results | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 56 | 0.0 |
Aged | 7 | 0.0 |
Esophagus/physiology | 2 | 22.0 |
Middle Aged | 14 | 0.0 |
*Physical Endurance | 2 | 4.0 |
Pressure | 3 | 2.0 |
*Respiration | 2 | 5.0 |
Animals | 23 | 0.0 |
*Gene Expression | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 8 | 0.0 |
Blotting, Western | 2 | 0.0 |
Carrier Proteins/*metabolism | 4 | 0.0 |
Cell Differentiation | 4 | 0.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Hair Follicle/cytology/*metabolism | 2 | 100.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
Proto-Oncogene Proteins c-myc/*metabolism | 11 | 11.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 18 | 0.0 |
Time Factors | 6 | 0.0 |
Adolescent | 6 | 0.0 |
English Abstract | 4 | 0.0 |
Respiratory Muscles/*physiology | 2 | 28.0 |
Cell Division | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
*Genes, myc | 5 | 2.0 |
Immunohistochemistry | 2 | 0.0 |
*Multigene Family | 2 | 0.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Transcription Factors/*genetics/*metabolism | 2 | 1.0 |
Models, Biological | 2 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
Cells, Cultured | 6 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Dimerization | 4 | 0.0 |
Gene Expression | 3 | 0.0 |
Mice | 14 | 0.0 |
Molecular Sequence Data | 20 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Transfection | 8 | 0.0 |
*Transcription Factors | 10 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
*Exercise | 2 | 1.0 |
Forced Expiratory Volume | 2 | 2.0 |
Oxygen Consumption | 4 | 1.0 |
*Pulmonary Ventilation | 2 | 22.0 |
Rest | 3 | 6.0 |
*Tidal Volume | 2 | 100.0 |
Cell Line | 9 | 0.0 |
*Promoter Regions (Genetics) | 4 | 0.0 |
Proto-Oncogene Proteins c-myc/metabolism | 2 | 2.0 |
Repressor Proteins/*physiology | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
RNA/*analysis | 2 | 11.0 |
Base Sequence | 14 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Protein Binding | 9 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Child | 3 | 0.0 |
Cytoplasm/*metabolism | 2 | 1.0 |
*Intracellular Signaling Peptides and Proteins | 4 | 0.0 |
3T3 Cells | 5 | 0.0 |
Hela Cells | 5 | 0.0 |
Helix-Loop-Helix Motifs | 4 | 1.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Interferon Inducers/*metabolism | 2 | 100.0 |
*Protein Structure, Tertiary | 2 | 1.0 |
Subcellular Fractions/*metabolism | 2 | 10.0 |
Cell Differentiation/drug effects/physiology | 2 | 2.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Oligonucleotides | 2 | 3.0 |
*Transcription, Genetic | 2 | 0.0 |
*Helix-Loop-Helix Motifs | 5 | 5.0 |
*Leucine Zippers | 3 | 6.0 |
Proto-Oncogene Proteins c-myc/genetics | 2 | 3.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 5 | 0.0 |
Microcirculation | 2 | 0.0 |
Regional Blood Flow | 2 | 1.0 |
Exercise/*physiology | 3 | 0.0 |
Reference Values | 3 | 0.0 |
*Carrier Proteins | 4 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
*Repressor Proteins | 6 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Blotting, Southern | 2 | 0.0 |
Genes, myc/genetics | 2 | 2.0 |
HL-60 Cells | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Binding Sites | 5 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Genes, myc | 2 | 0.0 |
Protein Hybridization | 2 | 3.0 |
Structure-Activity Relationship | 2 | 0.0 |
Biological Transport | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Rats | 4 | 0.0 |
DNA-Binding Proteins/isolation & purification/*metabolism | 2 | 2.0 |
Leucine Zippers | 2 | 1.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Blood Gas Analysis | 2 | 5.0 |
Respiratory Function Tests | 2 | 1.0 |
Analysis of Variance | 2 | 0.0 |
Spirometry | 2 | 6.0 |
Predictive Value of Tests | 2 | 0.0 |
Respiratory Muscles/*physiopathology | 2 | 25.0 |
Half-Life | 3 | 0.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis/metabolism | 2 | 2.0 |
Transcription, Genetic | 2 | 0.0 |
Exercise Test | 2 | 0.0 |
Anoxia/*physiopathology | 2 | 4.0 |
Exertion/*physiology | 4 | 6.0 |
Regression Analysis | 2 | 0.0 |
Lung Volume Measurements | 2 | 9.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Administration, Oral | 3 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Proto-Oncogene Proteins c-myc/genetics/*metabolism | 2 | 4.0 |
Cross Reactions | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Random Allocation | 2 | 0.0 |
Infusions, Intravenous | 2 | 0.0 |
Dehydration/metabolism | 2 | 40.0 |
Drug Evaluation | 2 | 0.0 |
*Exertion | 2 | 1.0 |
*Heat | 2 | 1.0 |
Metabolic Clearance Rate | 2 | 0.0 |
Theophylline/administration & dosage/*metabolism | 2 | 100.0 |